ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Rifkin (Rocky Mountain Cancer Center, Denver, USA) chairs an expert panel discussion with Prof Lonial (Emory Cancer Institute, Atlanta, USA), Dr Smith (Dana-Farber Cancer Institute, Boston, USA), Prof Terpos (University of Athens, Athens, Greece) and Dr Shah (University of California, San Francisco, USA) on the latest in relapsed/refractory multiple myeloma with emphasis on immunotherapy.
Read more...

;